NATRECOR Drug Patent Profile
✉ Email this page to a colleague
When do Natrecor patents expire, and when can generic versions of Natrecor launch?
Natrecor is a drug marketed by Scios Llc and is included in one NDA.
The generic ingredient in NATRECOR is nesiritide recombinant. There are two drug master file entries for this compound. Additional details are available on the nesiritide recombinant profile page.
Summary for NATRECOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 33 |
Drug Prices: | Drug price information for NATRECOR |
DailyMed Link: | NATRECOR at DailyMed |
Recent Clinical Trials for NATRECOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Virginia Commonwealth University | Phase 4 |
John C Burnett | Phase 1/Phase 2 |
National Institutes of Health (NIH) | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for NATRECOR
US Patents and Regulatory Information for NATRECOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NATRECOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NATRECOR
See the table below for patents covering NATRECOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 891792 | ⤷ Try a Trial | |
Canada | 1339210 | TECHNIQUES RECOMBINANTES POUR LA PRODUCTION DE NOUVEAUX NATRIURETIQUES ET DE PEPTIDES VASODILATATEURS (RECOMBINANT TECHNIQUES FOR PRODUCTION OF NOVEL NATRIURETIC AND VASODILATOR PEPTIDES) | ⤷ Try a Trial |
Austria | 126522 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 8912069 | ⤷ Try a Trial | |
European Patent Office | 0418308 | TECHNIQUES RECOMBINANTES DE PRODUCTION DE NOUVEAUX PEPTIDES NATRIURETIQUES ET VASODILATATEURS. (RECOMBINANT TECHNIQUES FOR PRODUCTION OF NOVEL NATRIURETIC AND VASODILATOR PEPTIDES.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |